Literature DB >> 541534

[Combination chemotherapy of mitomycin-C, carboquone, 5-fluorouracil and OK-432 for inoperable gastric cancer (author's transl)].

Y Sakata, K Sugawara, Y Komatsu, Y Yoshida, S Nishimura, K Kikuchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 541534

Source DB:  PubMed          Journal:  Nihon Gan Chiryo Gakkai Shi        ISSN: 0021-4671


× No keyword cloud information.
  1 in total

1.  Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.

Authors:  Y Sakata; Y Komatsu; S Takagi; S Saitoh; T Itoh; H Suzuki; K Tsushima; D Sasaki; Y Yoshida
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.